Early Indication that NAC May Improve Dopamine Function in Parkinson’s

Early Indication that NAC May Improve Dopamine Function in Parkinson’s
Evidence highlighted in an article published in Clinical Pharmacology and Therapeutics further supports the urgent need for a full clinical trial of a candidate already selected by CPT’s International Linked Clinical Trial experts and for which CPT continues to seek funding: N- acetyl cysteine. CPT’s research team comment that   “Again evidence accumulates to support the trial of candidates selected by ... read more
Source: The Cure Parkinson’s TrustPublished on 2019-07-15